Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Non-Current Assets (2022 - 2025)

Envoy Medical's Non-Current Assets history spans 4 years, with the latest figure at $2.4 million for Q3 2025.

  • For Q3 2025, Non-Current Assets rose 7.21% year-over-year to $2.4 million; the TTM value through Sep 2025 reached $9.5 million, up 71.12%, while the annual FY2024 figure was $2.6 million, 224.17% up from the prior year.
  • Non-Current Assets for Q3 2025 was $2.4 million at Envoy Medical, up from $2.4 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $427.2 million in Q3 2022 and bottomed at $750000.0 in Q1 2024.
  • The 4-year median for Non-Current Assets is $2.4 million (2025), against an average of $92.4 million.
  • The largest annual shift saw Non-Current Assets crashed 99.8% in 2023 before it surged 224.17% in 2024.
  • A 4-year view of Non-Current Assets shows it stood at $908000.0 in 2022, then dropped by 10.24% to $815000.0 in 2023, then soared by 224.17% to $2.6 million in 2024, then dropped by 8.25% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Non-Current Assets are $2.4 million (Q3 2025), $2.4 million (Q2 2025), and $2.1 million (Q1 2025).